Skip to content
10-Q

Quarterly Report

ORAMED PHARMACEUTICALS INC. ORMP

0001213900-25-044193

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 14, 2025 40.85M sh
Stockholders Equity Q1 2025 · Mar 31, 2025 $140.81M
Stockholders Equity Q1 2025 · Dec 31, 2024 $146.27M
Current Liabilities Q1 2025 · Mar 31, 2025 $5.49M
Current Liabilities Q1 2025 · Dec 31, 2024 $5.69M
Current Assets Q1 2025 · Mar 31, 2025 $131.48M
Current Assets Q1 2025 · Dec 31, 2024 $143.22M
Total Assets Q1 2025 · Mar 31, 2025 $147.54M
Total Assets Q1 2025 · Dec 31, 2024 $155.28M
Shares Diluted Q1 2025 · Mar 31, 2024 41.56M sh
Capex Q1 2025 · Mar 31, 2024 $2K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$1.48M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.04
Eps Basic Q1 2025 · Mar 31, 2024 $0.04
Sga Expense Q1 2025 · Mar 31, 2024 $1.78M
Rd Expense Q1 2025 · Mar 31, 2024 $1.18M
Net Income Q1 2025 · Mar 31, 2024 $1.54M
Operating Income Q1 2025 · Mar 31, 2024 −$2.96M